Recent LGVN News
- Longeveron® Announces Completion of Successful Investigator Meeting for On-going Phase 2b Clinical Trial Evaluating Lomecel-B™ as a Potential Treatment for HLHS, a Rare Pediatric Cardiac Disease • GlobeNewswire Inc. • 06/11/2024 01:00:00 PM
- Longeveron® Announces Contract Development and Manufacturing Business and First Contract • GlobeNewswire Inc. • 06/03/2024 01:00:00 PM
- Longeveron® to Attend BIO International Convention 2024 • GlobeNewswire Inc. • 05/28/2024 12:05:00 PM
- Longeveron Announces First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/14/2024 08:05:00 PM
- Longeveron Announces Board of Directors Planned Transitions • GlobeNewswire Inc. • 05/10/2024 08:05:00 PM
- Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 • GlobeNewswire Inc. • 05/02/2024 12:03:00 PM
- Longeveron to Present at the Planet MicroCap Showcase • GlobeNewswire Inc. • 04/25/2024 08:05:00 PM
- Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering • GlobeNewswire Inc. • 04/18/2024 08:05:00 PM
- Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds • GlobeNewswire Inc. • 04/17/2024 12:00:00 PM
- Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC) • GlobeNewswire Inc. • 04/15/2024 12:30:00 PM
- Longeveron Announces Closing of $5.2 Million Public Offering • GlobeNewswire Inc. • 04/11/2024 09:17:27 PM
- Longeveron Announces Pricing of $5.25 Million Public Offering • GlobeNewswire Inc. • 04/08/2024 06:15:00 PM
- Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals • GlobeNewswire Inc. • 04/08/2024 12:30:00 PM
- IBN Announces Latest Episode of The Bell2Bell Podcast featuring Wa’el Hashad, CEO of Longeveron Inc. • GlobeNewswire Inc. • 11/14/2023 01:17:00 PM
- IBN Coverage Initiated for Longeveron Inc. • GlobeNewswire Inc. • 09/07/2023 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2023 09:00:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2023 09:00:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2023 09:00:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2023 09:00:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 08:34:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2023 09:27:03 PM
- Form CERT - Certification by an exchange approving securities for listing • Edgar (US Regulatory) • 08/16/2023 05:21:55 PM
- Form 8-A12B - Registration of securities [Section 12(b)] • Edgar (US Regulatory) • 08/14/2023 08:55:05 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/14/2023 08:45:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:30:11 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM